The scale of the problem remains staggering. Sepsis, the life-threatening organ dysfunction caused by a dysregulated host response to infection, continues to rank among the leading causes of death worldwide, accounting for millions of deaths each year despite major advances in recognition and management. Global estimates of hospital-treated sepsis underscore the enormous incidence and mortality burden, and the economic consequences extend far beyond the acute hospital stay. Survivors frequently require prolonged rehabilitation, recurrent healthcare use and long-term nursing support, and many lose their independence entirely. Epidemiological studies from Germany, for example, have documented the substantial costs and care dependency that follow sepsis hospitalization, painting a picture of a condition whose true burden is measured in years, not days.

Crucially, mortality statistics capture only part of that burden. A growing body of evidence shows that increasing numbers of sepsis survivors experience persistent cognitive impairment, physical disability, psychological distress and markedly reduced quality of life. Landmark follow-up studies of patients who survived acute respiratory distress syndrome, a condition closely intertwined with sepsis in the intensive care unit, revealed functional disability persisting five years after critical illness, while systematic reviews have shown that many critical illness survivors struggle to return to employment, with lasting psychosocial consequences. These findings suggest that success in sepsis care should be measured not only by survival but by the quality and meaning of that survival for patients and their families, including the often-overlooked burden carried by caregivers, who face psychological, physical, social and financial challenges of their own.

The editorial also emphasizes a clinical reality that is frequently obscured by the language of emergency medicine: sepsis is not always an isolated and reversible disease process. For some patients, it represents a transient physiological insult from which meaningful recovery is expected. For others, it may be the final manifestation of advanced malignancy, severe frailty, end-stage organ failure or another life-limiting condition. In such situations, aggressive organ support and life-sustaining therapies may prolong life without achieving outcomes that patients would consider acceptable. Recognizing this heterogeneity, the authors argue, is essential when defining treatment goals and evaluating whether ongoing interventions remain appropriate. A one-size-fits-all approach that maximizes physiological parameters in every patient risks delivering care that is technically successful but profoundly misaligned with individual values.

To address this, the authors propose viewing sepsis and septic shock as a trajectory rather than a single event. During the acute phase, which generally covers the first several hours after recognition and extends through the first 24 to 72 hours, survival remains the primary objective. Early recognition, rapid diagnosis and prompt initiation of evidence-based therapies are essential, and the campaign’s guidelines have extensively addressed this phase over the last 25 years. Patients and families should be involved in decision-making whenever possible, even though this is often difficult during the initial stages of critical illness, when both families and clinicians typically prioritize survival. Still, the editorial stresses that even in the acute phase clinicians should consider whether initiating life-sustaining treatment is consistent with the patient’s wishes and values, a point of particular ethical weight because not starting treatment is often perceived as less difficult than withdrawing it later.

The acute phase is followed by a period of ongoing critical illness that may last for days or weeks, depending on the patient’s clinical course. During this stage, clinicians must reassess prognosis, treatment options and the balance between the burden of interventions and the likelihood of meaningful recovery. Patient goals and values should be revisited as clinical circumstances evolve, linking medical interventions to outcomes that are meaningful to patients rather than focusing solely on survival. The authors point to the concept of goal-directed health care, which redefines health and health care in the era of value-based medicine, and to consensus frameworks from other acute specialties, such as stroke, that have already embedded goal-concordant care into quality improvement standards. Such an approach, they argue, may strengthen therapeutic relationships, support shared decision-making and improve adherence to treatment plans.

Culture, communication and belief systems occupy a central place in this vision. Cultural identity encompasses not only ethnicity, language and religion but also family structures, values and beliefs about illness, death and healthcare itself. Care plans should address patients’ preferences, life goals and cultural context, and healthcare systems may need culturally specific resources to bridge communication gaps and support equitable care. The editorial cites the multinational ETHICATT study, which demonstrated that religion and religiosity significantly influence end-of-life decisions and patient autonomy in intensive care units across different countries, and in some settings religious beliefs may also shape the legal and ethical dimensions of end-of-life decision-making. Effective, structured communication is presented as fundamental throughout the entire course of sepsis, ensuring that patients and families are informed, heard and able to participate in decisions aligned with the patient’s goals and values.

Yet the evidence suggests this component of care remains underdeveloped. Research on sepsis hospitalizations has documented persistent deficits in the identification of patient goals and in the delivery of goal-concordant care after discharge. Prognostic uncertainty, time pressures and the traditional focus on physiological stabilization contribute to delayed conversations about treatment preferences. Policy statements from the American College of Critical Care Medicine and the American Thoracic Society have established shared decision-making as a standard in intensive care, and practical guidance on evidence-based ICU family conferences and the fine-tuning of family partnerships in decision-making provide clinicians with tested frameworks. Evidence also indicates that involving palliative care specialists can improve communication, facilitate decision-making and reduce potentially non-beneficial interventions without compromising quality of care, including for older adults hospitalized with septic shock. The editorial’s conclusion is unambiguous: communication should be considered a core component of high-quality sepsis management rather than an adjunct to it.

As patients enter the recovery phase, attention must shift toward functional outcomes, quality of life and psychological well-being, with comprehensive rehabilitation and follow-up programs recognized as essential components of recovery after sepsis. The authors acknowledge that the 2026 Surviving Sepsis Campaign guidelines have already moved in this direction, including Good Practice Statements in areas where high-certainty evidence is difficult to generate, and offering recommendations on goals-of-care discussions, advance directives, time-limited trials, palliative care and long-term outcomes. But they argue that future guidelines should go further, giving greater prominence to outcomes such as functional independence, cognitive performance, psychological well-being and caregiver burden. Where evidence is limited, recommendations may appropriately be informed by professional standards, ethical principles, patient values and societal goals, a stance the authors insist does not weaken evidence-based medicine but increases its transparency. The future of sepsis care, they conclude, lies not in departing from evidence-based medicine but in expanding it toward value-informed, goal-centred care, in which survival remains vital but is recognized as only one of several outcomes patients may value, alongside dignity, meaningful relationships, freedom from prolonged suffering and symptom control.

Subject of Research: Patient-centred, goal-concordant sepsis care within the Surviving Sepsis Campaign guidelines

Article Title: Surviving Sepsis Campaign beyond survival: aligning sepsis care with patient goals

Article References: Kesecioglu, J., Metaxa, V., & Azoulay, E. (2026). Surviving Sepsis Campaign beyond survival: aligning sepsis care with patient goals. Intensive Care Medicine. https://doi.org/10.1007/s00134-026-08590-4

Image Credits: AI Generated

DOI: 10.1007/s00134-026-08590-4

Keywords: sepsis, septic shock, Surviving Sepsis Campaign, intensive care, shared decision-making, palliative care, goals of care, patient-centred care, post-sepsis morbidity, critical illness recovery, end-of-life care, clinical guidelines

The authors used a structured descriptive approach rather than a formal guideline process. For each recommendation, they identified the predominant study design, judged the consistency of findings across available studies, summarised residual uncertainties, and assigned a descriptive evidence-strength label of high, moderate, low, or insufficient. This transparency is important, because the headline conclusion is sobering: the evidence underpinning many widely practised rehabilitation strategies remains limited and heterogeneous, preventing firm recommendations and leaving clinicians to navigate a field where well-established physiological reasoning is not always matched by rigorous trial data.

Underpinning the syndrome is a cascade of biological injury that begins in the acute phase. The strongest evidence points to early neuromuscular damage and rapid skeletal-muscle wasting during critical illness. ICU-acquired weakness, the hallmark of physical PICS, reflects a combination of critical illness myopathy, polyneuropathy, and disuse atrophy, driven by enhanced proteolysis through the ubiquitin-proteasome and autophagy pathways, suppressed protein synthesis, oxidative stress, mitochondrial dysfunction, and impaired excitation-contraction coupling. Beyond the loss of muscle mass, persistent alterations in muscle metabolism, mitochondrial bioenergetics, and gene expression have been documented in survivors, and emerging work implicates epigenetic changes such as altered DNA methylation detectable years after ICU admission.

The brain is similarly vulnerable. Systemic inflammation can compromise the blood-brain barrier, allowing peripheral mediators to trigger central neuroinflammation. Activated microglia and disrupted neuronal networks contribute to cognitive dysfunction and mood disturbance, while hypoxaemia, impaired cerebral autoregulation, and microvascular injury exacerbate neuronal vulnerability. Structural imaging frequently reveals white-matter abnormalities associated with long-term cognitive deficits, and critical illness episodes have been linked to accelerated cognitive decline resembling that seen after moderate traumatic brain injury. Neuroendocrine disruption affecting the hypothalamic-pituitary-adrenal, thyroid, and gonadal axes may contribute to catabolism, metabolic dysregulation, and impaired recovery, persisting in some patients for five years or more. Frailty occupies a bidirectional position, serving both as a risk factor for critical illness and as a consequence of it, further complicating attribution of long-term impairments.

Defining the syndrome itself remains contested. The 2012 consensus definition requires impairment in at least one of the three core domains, and the authors argue against tightening this threshold, noting that multidomain impairment is relatively uncommon, affecting roughly a quarter of survivors at three months and about 21 percent at twelve months, while single-domain impairment still carries substantial functional cost. PICS overlaps with post-sepsis syndrome, chronic critical illness, post-COVID conditions, and myalgic encephalomyelitis/chronic fatigue syndrome, and attribution is further complicated by pre-existing cognitive impairment, psychiatric illness, and physical disability. Because no dedicated International Classification of Diseases code exists for PICS, coding, reimbursement, and sustainable staffing remain barriers, although a national code has recently been approved in Germany.

On assessment, the review recommends a pragmatic two-step pathway based on expert consensus rather than validated diagnostic criteria. Brief screening tools, including the PHQ-4 for mental health, the Mini-Cog for cognition, and the Timed Up-and-Go for physical function, are applied to all survivors, with comprehensive multidisciplinary evaluation reserved for those who screen positive, ideally around three months after hospital discharge and with reassessment at six and twelve months. Additional clinically relevant domains, including fatigue affecting more than half of survivors in the first year, post-extubation dysphagia, persistent pain reported by roughly a third to a half of survivors, sleep disturbance, and health-related quality of life, are inconsistently captured. Return to work integrates all three core domains and is starkly affected: roughly two-thirds of previously employed survivors remain jobless at three months, and about 40 percent at twelve months.

Prevention starts in the ICU with the ABCDEF bundle, which combines pain assessment, spontaneous awakening and breathing trials, light sedation, delirium prevention, early mobilisation, and family engagement. Higher bundle performance is consistently associated with less delirium, shorter mechanical ventilation, reduced length of stay, and a higher likelihood of discharge home, although effects on mortality are inconsistent and long-term functional outcomes remain insufficiently studied. Early mobilisation, defined as mobilisation within 72 hours of ICU admission including passive and active components, shows short-term benefits in trials and meta-analyses, but long-term evidence is conflicting and appears to depend on dose and comparator. No trial has directly compared mobilisation doses, a gap identified as the highest research priority and now being addressed by the ESICM’s first international study, ERUPT. Adverse-event rates are below three percent and typically transient, with safety demonstrated even during extracorporeal membrane oxygenation, renal replacement therapy, and vasopressor support.

The transition from ICU to the general ward represents a high-risk window. In a UK survey of 25 centres, 98 percent of patients required ongoing physiotherapy and 70 percent were at risk of malnutrition, yet ward-based rehabilitation is frequently fragmented by competing priorities, lower staffing ratios, and poor handovers, creating a so-called post-ICU gap that may erode gains achieved in intensive care. Structured multidisciplinary continuity of care, explicit rehabilitation goals, and standardised handovers covering mobilisation, nutrition, and outstanding risks are therefore emphasised. After hospital discharge, individualised multimodal rehabilitation across inpatient, outpatient, community, and home-based models is supported, and meta-analyses show fairly consistent improvement in aerobic capacity, rated high-certainty in one synthesis of fourteen randomised trials, but effects on quality of life are inconsistent. Three components remain chronically under-delivered: structured pharmacist-led medication review of psychoactive drugs carried forward from the ICU, explicit treatment rather than mere measurement of pain, fatigue, sleep disturbance, and dysphagia, and vocational rehabilitation to support return to work.

The organisation of post-ICU recovery services varies dramatically across health systems, from well-integrated national follow-up programmes in parts of Europe to very limited provision elsewhere. A cautionary finding emerges from a 2024 randomised trial in which a hospital-based, intensivist-led multidisciplinary consultation model produced worse one-year outcomes than standard follow-up, possibly because the intervention was largely diagnostic and referral-based, with treatment changes in fewer than eight percent of patients and modest attendance. The authors argue this does not undermine survivorship care itself, but rather exposes the danger of assuming that a single clinic-centred model suits every survivor. Emerging approaches, including telehealth, virtual reality, and peer-support programmes, aim to widen access, though evidence remains preliminary and digital barriers persist for frail or remote patients.

On the family dimension, the review reframes PICS-family through a systems perspective in which critical illness affects the family as an interdependent biopsychosocial unit, shaping and being shaped by the patient’s recovery trajectory. Nurse-led, multicomponent family interventions delivered during and after the ICU stay appear promising for improving communication, shared decision-making, and early psychological outcomes, whereas ICU diaries have not shown consistent benefit. The review closes with a research agenda: harmonised diagnostic criteria, longitudinal phenotyping of recovery trajectories, determination of the optimal dose and timing of rehabilitation, rigorous head-to-head comparison of follow-up models, mechanistic studies incorporating biomarkers and epigenetics, fair and transparent use of artificial intelligence for risk prediction, culturally and spiritually responsive care, and a universal ICD code. Until that agenda is fulfilled, the authors conclude, post-intensive care syndrome should be understood not as a static post-discharge diagnosis but as a dynamic recovery process spanning the entire continuum from intensive care admission to long-term survivorship.

Subject of Research: Post-intensive care syndrome and rehabilitation across the ICU recovery continuum

Article Title: Rehabilitation and the post-intensive care syndrome across the recovery continuum: a narrative review

Article References: Rehabilitation and the post-intensive care syndrome across the recovery continuum: a narrative review. (n.d.). https://doi.org/10.1007/s00134-026-08600-5

Image Credits: AI Generated

DOI: 10.1007/s00134-026-08600-5

Keywords: post-intensive care syndrome, critical illness recovery, ICU-acquired weakness, rehabilitation, ABCDEF bundle, early mobilisation, cognitive impairment, PICS-family, ICU follow-up, neuroinflammation, skeletal muscle wasting, survivorship care

This rigorous trial enrolled 115 patients and investigated if this dual intervention could mitigate the profound muscle loss and physical debilitation commonly observed after severe illness. The rationale stemmed from prior evidence in frail and elderly populations, where combining exercise and protein supplementation showed promise in improving functional outcomes. However, this study’s findings diverged notably, revealing no statistically significant improvement over standard ICU care in measures such as mobility, physical strength, cognitive function, and quality of life up to six months post-discharge.

Dr. Dale Needham, the study’s lead author and a professor at Johns Hopkins University, emphasized that these results refine our understanding of recovery in critical illness. The trial demonstrated the safety and feasibility of delivering early rehabilitation alongside nutritional support during intensive care but underscored the complexity of biological responses during acute phases of critical illness. Researchers hypothesize that anabolic resistance—a diminished capacity to utilize protein effectively in the body’s early stressed state—may blunt the intended benefits of such nutritional interventions.

Beyond these primary outcomes, NEXIS sheds light on the heterogeneity of recovery trajectories among ICU survivors, highlighting a pressing need for personalized rehabilitation strategies that consider individual physiological and metabolic differences. Despite the absence of observable gains in this combined therapy, the sustained physical impairments in study participants reinforce the urgency for innovative therapeutic approaches.

The study’s outcomes pivot the field toward investigating alternative or adjunctive interventions that could more effectively counteract ICU-acquired weaknesses. This includes a focus on underlying molecular mechanisms, timing of interventions, and patient-specific factors contributing to recovery variability. The NEXIS trial exemplifies how rigorous clinical research can challenge entrenched assumptions and pave the way for future breakthroughs.

This work also builds on decades of pioneering efforts at Johns Hopkins Medicine, where researchers have established foundational knowledge on ICU rehabilitation and long-term recovery science. The trial’s extensive data set will inform the next generation of studies aiming to tailor critical care rehabilitation protocols to maximize functional outcomes and quality of life for survivors of acute respiratory failure worldwide.

Ultimately, while the NEXIS Trial did not confirm the hypothesized benefits of combined exercise and protein supplementation during critical illness, it delineates a clearer pathway for future inquiries. By fostering a nuanced appreciation of biological complexities and recovery dynamics, it steers critical care research towards more targeted, effective interventions capable of transforming patient recovery after ICU discharge.

Subject of Research: Recovery interventions for critically ill patients

Article Title: Nutrition and Exercise in Critical Illness (NEXIS) Trial: Combined Rehabilitation and Nutrition in Acute Respiratory Failure

News Publication Date: July 13, 2023

Web References:
https://academic.oup.com/ajrccm/advance-article/doi/10.1093/ajrccm/aamag287/8732445?searchresult=1

Keywords: critical illness, ICU rehabilitation, acute respiratory failure, nutrition, protein supplementation, exercise therapy, anabolic resistance, physical recovery